HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rubén Nogueiras Selected Research

Fatty Acids (Saturated Fatty Acids)

11/2021Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis.
2/2021Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation.
1/2018Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.
3/2015Pregnancy induces resistance to the anorectic effect of hypothalamic malonyl-CoA and the thermogenic effect of hypothalamic AMPK inhibition in female rats.
6/2012Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rubén Nogueiras Research Topics

Disease

41Obesity
04/2024 - 03/2003
27Body Weight (Weight, Body)
04/2024 - 07/2002
13Insulin Resistance
01/2022 - 03/2003
10Weight Loss (Weight Reduction)
02/2024 - 09/2010
9Weight Gain
08/2022 - 01/2011
8Inflammation (Inflammations)
05/2024 - 05/2014
7Hyperthyroidism
01/2022 - 03/2003
7AIDS-Related Complex (ARC)
10/2018 - 08/2010
6Non-alcoholic Fatty Liver Disease
11/2021 - 03/2016
6Hyperphagia (Overeating)
01/2021 - 01/2011
4Pre-Eclampsia (Preeclampsia)
01/2023 - 08/2015
4Fatty Liver
11/2021 - 03/2016
4Neoplasms (Cancer)
01/2021 - 03/2006
4Type 2 Diabetes Mellitus (MODY)
01/2019 - 03/2003
3Liver Diseases (Liver Disease)
05/2024 - 03/2010
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 10/2007
3Malnutrition (Nutritional Deficiencies)
01/2010 - 07/2002
2Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2021
2Hypertrophy
11/2020 - 06/2015
2Glucose Intolerance
11/2016 - 03/2016
1Metabolic Diseases (Metabolic Disease)
04/2024
1Morbid Obesity
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1Body Weight Changes
03/2022
1Cognitive Dysfunction
01/2022
1Experimental Arthritis
01/2022
1Bardet-Biedl syndrome 1
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2021

Drug/Important Bio-Agent (IBA)

12GhrelinIBA
08/2022 - 07/2002
11Glucose (Dextrose)FDA LinkGeneric
02/2021 - 01/2010
10LipidsIBA
01/2024 - 03/2010
10AMP-Activated Protein KinasesIBA
01/2022 - 09/2010
9Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2011
7LeptinIBA
01/2023 - 01/2010
6Thyroid HormonesIBA
01/2022 - 03/2003
6NicotineFDA Link
02/2021 - 04/2012
6Insulin (Novolin)FDA Link
01/2021 - 01/2010
5Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2022 - 01/2011
5Fatty Acids (Saturated Fatty Acids)IBA
11/2021 - 06/2012
5Peptides (Polypeptides)IBA
01/2020 - 10/2007
4Hormones (Hormone)IBA
04/2024 - 03/2003
4Phosphotransferases (Kinase)IBA
01/2018 - 06/2015
4AdiponectinIBA
04/2013 - 08/2004
4Messenger RNA (mRNA)IBA
06/2012 - 07/2002
4NeuropeptidesIBA
06/2012 - 08/2010
4Neuropeptide YIBA
06/2012 - 08/2010
4Agouti-Related ProteinIBA
06/2012 - 08/2010
3EnzymesIBA
01/2021 - 09/2008
3Triglycerides (Triacylglycerol)IBA
06/2019 - 03/2016
3Endoplasmic Reticulum Chaperone BiPIBA
07/2018 - 10/2014
2Exenatide (Byetta)FDA Link
04/2024 - 01/2020
2Sirtuin 1IBA
01/2023 - 01/2012
2Estrogens (Estrogen)FDA Link
03/2022 - 08/2008
2kappa Opioid Receptors (kappa Opioid Receptor)IBA
03/2022 - 11/2016
2Methionine (L-Methionine)FDA Link
01/2022 - 01/2018
2Methionine AdenosyltransferaseIBA
01/2022 - 01/2021
2fibroblast growth factor 21IBA
01/2022 - 01/2022
2Steroidogenic Factor 1IBA
10/2021 - 11/2018
2LigandsIBA
02/2021 - 01/2020
2OrexinsIBA
02/2021 - 03/2015
2Choline (Choline Chloride)IBA
01/2021 - 01/2018
2uroguanylinIBA
03/2019 - 01/2018
2Appetite Depressants (Anorectics)IBA
10/2018 - 03/2015
2CeramidesIBA
10/2018 - 10/2014
2Glucagon-Like Peptide 1 (GLP 1)IBA
11/2016 - 04/2015
2Antipsychotic Agents (Antipsychotics)IBA
01/2016 - 01/2011
2Triiodothyronine (Liothyronine)FDA LinkGeneric
06/2012 - 09/2010
2Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
06/2012 - 09/2010
2SteroidsIBA
08/2008 - 03/2003
2ResistinIBA
09/2005 - 03/2003
1Biomarkers (Surrogate Marker)IBA
05/2024
1IncretinsIBA
04/2024
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
04/2024
1Glucagon Receptors (Glucagon Receptor)IBA
04/2024
1Glucagon-Like Peptide ReceptorsIBA
04/2024
1Dietary ProteinsIBA
02/2024
1GTP Phosphohydrolases (GTPases)IBA
01/2024
1AdipokinesIBA
01/2024
1Leptin ReceptorsIBA
01/2023
1NAD (NADH)IBA
01/2023
1Interleukin-12 (IL 12)IBA
01/2023
1Estradiol (Delestrogen)FDA LinkGeneric
03/2022
12- methyl- N- ((2'- (pyrrolidin- 1- ylsulfonyl)biphenyl- 4- yl)methyl)propan- 1- amineIBA
03/2022
1Antisense OligonucleotidesIBA
01/2022
1CytokinesIBA
01/2022
1Bone Morphogenetic Protein ReceptorsIBA
01/2022
1Staphylococcal Protein A (Protein A)IBA
01/2022
1PregnenoloneIBA
01/2022
1A-factor (Streptomyces)IBA
01/2022
1UbiquitinIBA
11/2021
1Oleic Acid (Oleate)IBA
11/2021
1pevonedistatIBA
11/2021
1FructoseIBA
02/2021

Therapy/Procedure

7Therapeutics
04/2024 - 04/2012
3Ovariectomy (Oophorectomy)
03/2022 - 08/2008
2Bariatric Surgery
04/2024 - 01/2022
2Oral Administration
11/2021 - 01/2018
1Drug Therapy (Chemotherapy)
04/2024
1Gastric Bypass (Roux-en-Y Gastric Bypass)
02/2024
1Intravenous Injections
10/2021